Craft

Pharmanutra

Stock Price

€56.8

2024-10-29

Market Capitalization

€545.7 M

2024-10-29

Revenue

€115.5 M

FY, 2024

Pharmanutra Summary

Company Summary

Overview
Pharmanutra, a pharmaceutical company, engages in the research, design, development, and marketing of nutraceutical supplements and medical devices. It also manufactures and distributes active ingredients for the pharmaceutical, food, and dietary supplement industry; and develops and distributes medicines, medical devices, OTC products, and nutritional supplements with focus on the pediatric area. The Company distributes and sells its products through sales representatives and wholesalers to pharmacies and para-pharmacies.
Type
Public
Status
Active
Founded
2003
HQ
Pisa, IT | view all locations
Website
http://www.pharmanutra.it/en/
Cybersecurity rating
Sectors

Key People

  • Andrea Lacorte

    Andrea Lacorte, Chairman of the Board of Directors and Executive Director

    • Roberto Lacorte

      Roberto Lacorte, Vice Chairman of the Board of Directors and Executive Director

      • Germano Tarantino

        Germano Tarantino, Executive Director & Scientific Director

        • Michele Lorenzini, Chairman of the Board of Statutory Auditors

          LocationsView all

          2 locations detected

          • Pisa, Toscana HQ

            Italy

            Via delle Lenze, 216/b

          • Pisa, Toscana

            Italy

            Via Campodavela 1

          Pharmanutra Financials

          Summary Financials

          Revenue (Q3, 2025)
          €32.7M
          Gross profit (Q3, 2025)
          €31.6M
          Net income (Q3, 2025)
          €4.8M
          Cash (Q3, 2025)
          €14.8M
          EBIT (Q3, 2025)
          €7.9M
          Enterprise value
          $551.9M

          Footer menu